$EMMA
Emmaus Life Sciences, Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023063225 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $7.067M $5.018M
YoY Change 19.17% 1.6%
Cost Of Revenue $191.0K $214.0K
YoY Change -70.39% -60.37%
Gross Profit $6.876M $4.804M
YoY Change 30.1% 9.21%
Gross Profit Margin 97.3% 95.74%
Selling, General & Admin $5.355M $4.366M
YoY Change -13.27% -5.64%
% of Gross Profit 77.88% 90.88%
Research & Development $166.0K $414.0K
YoY Change -68.62% -4.17%
% of Gross Profit 2.41% 8.62%
Depreciation & Amortization $2.000K $7.000K
YoY Change -84.62% -22.22%
% of Gross Profit 0.03% 0.15%
Operating Expenses $5.521M $4.780M
YoY Change -17.63% -5.51%
Operating Profit $1.355M $24.00K
YoY Change -195.56% -103.64%
Interest Expense -$251.0K $1.909M
YoY Change -116.05% 25.59%
% of Operating Profit -18.52% 7954.17%
Other Income/Expense, Net $167.0K $180.0K
YoY Change 11.33% 2.86%
Pretax Income $1.097M $105.0K
YoY Change 407.87% -124.65%
Income Tax -$112.0K $38.00K
% Of Pretax Income -10.21% 36.19%
Net Earnings $1.209M $67.00K
YoY Change 504.5% -117.14%
Net Earnings / Revenue 17.11% 1.34%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 53.64M 53.64M
Diluted Shares Outstanding 138.4M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.547M $1.510M
YoY Change 26.03% 28.07%
Cash & Equivalents $2.547M $1.505M
Short-Term Investments
Other Short-Term Assets $596.0K $647.0K
YoY Change 32.74% 26.61%
Inventory $1.711M $1.650M
Prepaid Expenses $536.0K $736.0K
Receivables $5.524M $4.587M
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.51M $9.257M
YoY Change 83.0% 45.05%
LONG-TERM ASSETS
Property, Plant & Equipment $59.00K $60.00K
YoY Change -21.33% -24.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $20.98M $17.74M
YoY Change 11.42% 6.89%
Other Assets $296.0K $293.0K
YoY Change 12.55% 13.13%
Total Long-Term Assets $23.67M $38.20M
YoY Change -43.56% 6.64%
TOTAL ASSETS
Total Short-Term Assets $11.51M $9.257M
Total Long-Term Assets $23.67M $38.20M
Total Assets $35.18M $47.45M
YoY Change -27.05% 12.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.887M $4.805M
YoY Change 55.54% 41.03%
Accrued Expenses $8.174M $8.164M
YoY Change 12.92% 42.5%
Deferred Revenue
YoY Change
Short-Term Debt $3.573M $3.670M
YoY Change -36.37% -50.75%
Long-Term Debt Due $24.60M $25.21M
YoY Change 14.57% 26.17%
Total Short-Term Liabilities $61.51M $60.92M
YoY Change 13.22% 46.71%
LONG-TERM LIABILITIES
Long-Term Debt $2.226M $3.560M
YoY Change -40.26% 5.29%
Other Long-Term Liabilities $17.36M $17.24M
YoY Change -20.04% -46.33%
Total Long-Term Liabilities $17.36M $17.24M
YoY Change -20.04% -46.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $61.51M $60.92M
Total Long-Term Liabilities $17.36M $17.24M
Total Liabilities $82.94M $83.78M
YoY Change 0.75% 5.0%
SHAREHOLDERS EQUITY
Retained Earnings -$256.1M -$257.3M
YoY Change 1.49% 1.89%
Common Stock $225.4M $222.5M
YoY Change 2.05% 0.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$47.76M -$36.33M
YoY Change
Total Liabilities & Shareholders Equity $35.18M $47.45M
YoY Change -27.05% 12.45%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $1.209M $67.00K
YoY Change 504.5% -117.14%
Depreciation, Depletion And Amortization $2.000K $7.000K
YoY Change -84.62% -22.22%
Cash From Operating Activities $1.037M $60.00K
YoY Change -38.16% -106.29%
INVESTING ACTIVITIES
Capital Expenditures $7.000K $0.00
YoY Change -12.5%
Acquisitions
YoY Change
Other Investing Activities $5.000K -$400.0K
YoY Change -100.47% -55.56%
Cash From Investing Activities -$2.000K -$400.0K
YoY Change -99.81% -55.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.000K 490.0K
YoY Change -101.76% -76.82%
NET CHANGE
Cash From Operating Activities 1.037M 60.00K
Cash From Investing Activities -2.000K -400.0K
Cash From Financing Activities -3.000K 490.0K
Net Change In Cash 1.032M 150.0K
YoY Change 31.46% -42.31%
FREE CASH FLOW
Cash From Operating Activities $1.037M $60.00K
Capital Expenditures $7.000K $0.00
Free Cash Flow $1.030M $60.00K
YoY Change -38.29% -106.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000822370
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35527
dei Entity Registrant Name
EntityRegistrantName
EMMAUS LIFE SCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0419387
dei Entity Address Address Line1
EntityAddressAddressLine1
21250 Hawthorne Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Torrance
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90503
dei City Area Code
CityAreaCode
310
dei Local Phone Number
LocalPhoneNumber
214-0065
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53637554
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1505000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2021000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4587000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
375000
CY2023Q3 us-gaap Inventory Net
InventoryNet
1650000
CY2022Q4 us-gaap Inventory Net
InventoryNet
2379000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1515000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1514000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
9257000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
6289000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75000
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
17737000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
18828000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2510000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2799000
CY2023Q3 emma Investment In Convertible Bond
InvestmentInConvertibleBond
17596000
CY2022Q4 emma Investment In Convertible Bond
InvestmentInConvertibleBond
19971000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
293000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
263000
CY2023Q3 us-gaap Assets
Assets
47453000
CY2022Q4 us-gaap Assets
Assets
48225000
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16285000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13549000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
831000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
703000
CY2023Q3 emma Conversion Feature Derivative Note Payable
ConversionFeatureDerivativeNotePayable
1251000
CY2022Q4 emma Conversion Feature Derivative Note Payable
ConversionFeatureDerivativeNotePayable
3248000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14400000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12917000
CY2023Q3 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
522000
CY2022Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
70000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
60917000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
54323000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2070000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2553000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17240000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21714000
CY2023Q3 us-gaap Liabilities
Liabilities
83783000
CY2022Q4 us-gaap Liabilities
Liabilities
82316000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53637554
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53637554
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49583501
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49583501
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
54000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
50000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
222439000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220815000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1503000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2619000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-257320000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-252337000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-36330000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-34091000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47453000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48225000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5018000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4939000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22530000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12460000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
214000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
540000
us-gaap Cost Of Revenue
CostOfRevenue
1151000
us-gaap Cost Of Revenue
CostOfRevenue
1943000
CY2023Q3 us-gaap Gross Profit
GrossProfit
4804000
CY2022Q3 us-gaap Gross Profit
GrossProfit
4399000
us-gaap Gross Profit
GrossProfit
21379000
us-gaap Gross Profit
GrossProfit
10517000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
414000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
432000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1023000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1196000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1497000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1664000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6345000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5076000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2869000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2963000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11826000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9413000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4780000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
5059000
us-gaap Operating Expenses
OperatingExpenses
19194000
us-gaap Operating Expenses
OperatingExpenses
15685000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
24000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-660000
us-gaap Operating Income Loss
OperatingIncomeLoss
2185000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5168000
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-647000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-421000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-647000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-421000
CY2023Q3 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
589000
CY2022Q3 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
51000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
1034000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
1341000
CY2023Q3 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
3069000
CY2022Q3 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
3850000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
2100000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
3235000
emma Gain Loss On Investment In Convertible Bond
GainLossOnInvestmentInConvertibleBond
-297000
emma Gain Loss On Investment In Convertible Bond
GainLossOnInvestmentInConvertibleBond
-133000
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-381000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-431000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1347000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1490000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-821000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1470000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3227000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5131000
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
181000
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
175000
us-gaap Interest And Other Income
InterestAndOtherIncome
514000
us-gaap Interest And Other Income
InterestAndOtherIncome
530000
CY2023Q3 us-gaap Interest Expense
InterestExpense
1909000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1520000
us-gaap Interest Expense
InterestExpense
5204000
us-gaap Interest Expense
InterestExpense
3544000
CY2023Q3 emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
81000
CY2022Q3 emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
234000
emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-7074000
emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-5613000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
105000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-426000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4889000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10781000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-35000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
67000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-391000
us-gaap Net Income Loss
NetIncomeLoss
-4942000
us-gaap Net Income Loss
NetIncomeLoss
-10825000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1614000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3047000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-249000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7112000
emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
403000
emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
7000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
225000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
481000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
962000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1455000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1389000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2566000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1116000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5650000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1322000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2957000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3826000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16475000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53637554
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49558501
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52414903
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49397690
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
138375065
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49558501
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52414903
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49397690
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-34091000
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
500000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-544000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
186000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3527000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-37439000
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1909000
CY2023Q2 emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
403000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
551000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1482000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-35032000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1614000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
225000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
67000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-36330000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21450000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
350000
CY2022Q1 emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
7000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
331000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1542000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-22299000
CY2022Q2 emma Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity
213000
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
110000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4415000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
643000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8892000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-34635000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3047000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
481000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-391000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-37589000
us-gaap Profit Loss
ProfitLoss
-4942000
us-gaap Profit Loss
ProfitLoss
-10825000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40000
emma Inventory Reserve
InventoryReserve
-85000
emma Inventory Reserve
InventoryReserve
-1240000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1849000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1303000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-3167000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-5072000
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-297000
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-133000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1347000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1490000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-647000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-421000
emma Gain Loss On Sale Of Loss On Leased Assets
GainLossOnSaleOfLossOnLeasedAssets
-22000
us-gaap Share Based Compensation
ShareBasedCompensation
1239000
us-gaap Share Based Compensation
ShareBasedCompensation
13000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
55000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
334000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
1034000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
1341000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
2100000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
3235000
emma Gain Loss On Option Instrument
GainLossOnOptionInstrument
32000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4215000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
485000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-636000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-390000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-176000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-66000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-446000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3237000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1479000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
95000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-3199000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3238000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
55000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2539000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6750000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2232000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2919000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000
emma Loan To Equity Method Investee
LoanToEquityMethodInvestee
-2647000
emma Loan To Equity Method Investee
LoanToEquityMethodInvestee
-4226000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-426000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1325000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5706000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4283000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
227000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5469000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1000000
emma Proceeds From Related Party Convertible Debt
ProceedsFromRelatedPartyConvertibleDebt
1000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5341000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2689000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
110000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2482000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7063000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-33000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-88000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-516000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1100000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2021000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2279000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1505000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1179000
us-gaap Interest Paid Net
InterestPaidNet
1679000
us-gaap Interest Paid Net
InterestPaidNet
817000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
35000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16000
emma Renewal Of Notes Payable Including Interests Capitalized
RenewalOfNotesPayableIncludingInterestsCapitalized
618000
emma Conversion Of Convertible Note Payable To Common Stock
ConversionOfConvertibleNotePayableToCommonStock
1500000
emma Newly Acquired Right Of Use Lease Asset
NewlyAcquiredRightOfUseLeaseAsset
189000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12460000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4805000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3785000
us-gaap Net Income Loss
NetIncomeLoss
-4900000
CY2023Q3 emma Working Capital Deficit
WorkingCapitalDeficit
51700000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
108292553
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
52635590
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5018000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4939000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22530000
CY2022Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
5491000
emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
5293000
emma Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales
RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales
52000
emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
4595000
CY2023Q3 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
6136000
CY2021Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
5153000
emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
3897000
emma Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales
RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales
-531000
emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
5012000
CY2022Q3 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
4569000
CY2023Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1362000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1393000
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
228000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
513000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5100000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5428000
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5040000
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4955000
CY2023Q3 us-gaap Inventory Net
InventoryNet
1650000
CY2022Q4 us-gaap Inventory Net
InventoryNet
2379000
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
132000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
598000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
736000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
467000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
647000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
449000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1515000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1514000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
515000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
505000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
455000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
430000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75000
CY2023Q3 us-gaap Depreciation
Depreciation
7000
CY2022Q3 us-gaap Depreciation
Depreciation
9000
us-gaap Depreciation
Depreciation
26000
us-gaap Depreciation
Depreciation
30000
CY2020Q3 us-gaap Debt Instrument Call Date Earliest
DebtInstrumentCallDateEarliest
2020-09-28
CY2022Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-126000
CY2022Q1 us-gaap Other Income
OtherIncome
41000
CY2023Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-106000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
626000
CY2023Q3 emma Accrued Selling Expenses
AccruedSellingExpenses
1542000
CY2022Q4 emma Accrued Selling Expenses
AccruedSellingExpenses
1363000
CY2023Q3 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
770000
CY2022Q4 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
650000
CY2023Q3 emma Accrued Non Employee Director Compensation
AccruedNonEmployeeDirectorCompensation
693000
CY2022Q4 emma Accrued Non Employee Director Compensation
AccruedNonEmployeeDirectorCompensation
484000
CY2023Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
397000
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
301000
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
19971000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
26100000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-2232000
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-2919000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
106000
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-126000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-249000
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-3084000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
17596000
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
19971000
CY2023Q3 emma Clinical And Regulatory Expenses
ClinicalAndRegulatoryExpenses
680000
CY2022Q4 emma Clinical And Regulatory Expenses
ClinicalAndRegulatoryExpenses
361000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
723000
CY2023Q3 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
590000
CY2022Q4 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
144000
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2726000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2381000
CY2023Q3 emma Accrued Payroll Salary And Taxes Current
AccruedPayrollSalaryAndTaxesCurrent
1310000
CY2022Q4 emma Accrued Payroll Salary And Taxes Current
AccruedPayrollSalaryAndTaxesCurrent
1263000
CY2023Q3 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
5131000
CY2022Q4 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
5536000
CY2023Q3 emma Accured Due To Customer Current
AccuredDueToCustomerCurrent
844000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
879000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
440000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8164000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7239000
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16285000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13549000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14400000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12917000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17240000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21714000
CY2023Q3 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
32505000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
1351000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
31184000
us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
90677626
CY2022Q4 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
30418000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
2918000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
27562000
CY2022 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
41644749
CY2023Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.11
CY2022Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.08
CY2023Q3 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.21
CY2022Q4 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.20
us-gaap Operating Lease Expense
OperatingLeaseExpense
878000
us-gaap Operating Lease Expense
OperatingLeaseExpense
868000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
24784000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3200000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2200000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2321000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
32505000
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
32000
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
84000
emma Warrants Granted Term
WarrantsGrantedTerm
P5Y
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
500000
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.5
CY2023Q3 emma Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
41000
emma Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
45000
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7500000
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.5
CY2023Q1 emma Class Of Warrant Or Right Period For Which Warrants Or Rights Exercisable
ClassOfWarrantOrRightPeriodForWhichWarrantsOrRightsExercisable
P5Y
us-gaap Share Based Compensation
ShareBasedCompensation
1200000
CY2023Q3 emma Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
548000
emma Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
989000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y2M12D
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-35000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
291000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
272000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
282000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1138000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1171000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
856000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3447000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
546000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2901000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2500000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2900000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.129

Files In Submission

Name View Source Status
0000950170-23-063225-index-headers.html Edgar Link pending
0000950170-23-063225-index.html Edgar Link pending
0000950170-23-063225.txt Edgar Link pending
0000950170-23-063225-xbrl.zip Edgar Link pending
emma-20230930.htm Edgar Link pending
emma-20230930.xsd Edgar Link pending
emma-ex10_1.htm Edgar Link pending
emma-ex10_2.htm Edgar Link pending
emma-ex10_3.htm Edgar Link pending
emma-ex31_1.htm Edgar Link pending
emma-ex31_2.htm Edgar Link pending
emma-ex32_1.htm Edgar Link pending
emma-ex4_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img109337448_0.jpg Edgar Link pending
img110260969_0.jpg Edgar Link pending
img110260969_1.jpg Edgar Link pending
img110260969_2.jpg Edgar Link pending
img110260969_3.jpg Edgar Link pending
img110260969_4.jpg Edgar Link pending
img110260969_5.jpg Edgar Link pending
img110260969_6.jpg Edgar Link pending
img111184490_0.jpg Edgar Link pending
img111184490_1.jpg Edgar Link pending
img111184490_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
emma-20230930_def.xml Edgar Link unprocessable
emma-20230930_pre.xml Edgar Link unprocessable
emma-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
emma-20230930_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
emma-20230930_cal.xml Edgar Link unprocessable